MDT Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-02-01 | Kirk Jennifer M | officer: Chief Accounting Officer | 10,115 | F-InKind | D | 672 | 85.77 | 57,637.44 |
| 2022-12-13 | Salmon Sean | officer: EVP & President Cardiovascular | 0 | M-Exempt | D | 14,823 | 55.32 | 820,008.36 |
| 2022-12-13 | Salmon Sean | officer: EVP & President Cardiovascular | 36,088 | S-Sale | D | 16,631 | 80.50 | 1,338,735.63 |
| 2022-12-13 | Salmon Sean | officer: EVP & President Cardiovascular | 52,719 | M-Exempt | A | 14,823 | 55.32 | 820,008.36 |
| 2022-12-13 | Salmon Sean | officer: EVP & President Cardiovascular | 37,896 | M-Exempt | A | 1,808 | 55.32 | 100,018.56 |
| 2022-12-09 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 32,830 | F-InKind | D | 5,206 | 78.59 | 409,139.54 |
| 2022-12-07 | Wall Brett A. | officer: EVP & Pres Neuroscience | 25,470 | F-InKind | D | 337 | 79.04 | 26,636.48 |
| 2022-12-07 | WHITE ROBERT JOHN | officer: EVP & Pres. Medical Surgical | 36,186 | F-InKind | D | 348 | 79.04 | 27,505.92 |
| 2022-12-07 | Salmon Sean | officer: EVP & President Cardiovascular | 36,088 | F-InKind | D | 300 | 79.04 | 23,712.00 |
| 2022-10-14 | TEN HOEDT ROB | officer: EVP and Pres. Global Regions | 0 | M-Exempt | D | 2,404 | 41.60 | 100,006.40 |
| 2022-10-14 | TEN HOEDT ROB | officer: EVP and Pres. Global Regions | 43,483 | S-Sale | D | 2,404 | 81.54 | 196,014.95 |
| 2022-10-14 | TEN HOEDT ROB | officer: EVP and Pres. Global Regions | 45,887 | M-Exempt | A | 2,404 | 41.60 | 100,006.40 |
| 2022-08-01 | Wall Brett A. | officer: EVP & Pres Neuroscience | 59,433 | A-Award | A | 59,433 | 93.08 | 5,532,023.64 |
| 2022-08-01 | Wall Brett A. | officer: EVP & Pres Neuroscience | 18,802 | A-Award | A | 18,802 | 0.00 | 0.00 |
| 2022-08-01 | Wall Brett A. | officer: EVP & Pres Neuroscience | 25,646 | A-Award | A | 7,521 | 0.00 | 0.00 |
| 2022-08-01 | Smith Gregory L | officer: EVP Global Ops & Supply Chain | 44,151 | A-Award | A | 44,151 | 93.08 | 4,109,575.08 |
| 2022-08-01 | Smith Gregory L | officer: EVP Global Ops & Supply Chain | 13,967 | A-Award | A | 13,967 | 0.00 | 0.00 |
| 2022-08-01 | Smith Gregory L | officer: EVP Global Ops & Supply Chain | 34,783 | A-Award | A | 5,587 | 0.00 | 0.00 |
| 2022-08-01 | TEN HOEDT ROB | officer: EVP & President EMEA | 57,735 | A-Award | A | 57,735 | 93.08 | 5,373,973.80 |
| 2022-08-01 | TEN HOEDT ROB | officer: EVP & President EMEA | 18,264 | A-Award | A | 18,264 | 0.00 | 0.00 |
| 2022-08-01 | TEN HOEDT ROB | officer: EVP & President EMEA | 43,483 | A-Award | A | 7,306 | 0.00 | 0.00 |
| 2022-08-01 | Salmon Sean | officer: EVP & President Cardiovascular | 67,924 | A-Award | A | 67,924 | 93.08 | 6,322,365.92 |
| 2022-08-01 | Salmon Sean | officer: EVP & President Cardiovascular | 21,487 | A-Award | A | 21,487 | 0.00 | 0.00 |
| 2022-08-01 | Salmon Sean | officer: EVP & President Cardiovascular | 36,214 | A-Award | A | 8,595 | 0.00 | 0.00 |
| 2022-08-01 | Kirk Jennifer M | officer: Chief Accounting Officer | 1,416 | A-Award | A | 1,416 | 93.08 | 131,801.28 |
| 2022-08-01 | Kirk Jennifer M | officer: Chief Accounting Officer | 18,679 | A-Award | A | 18,679 | 93.08 | 1,738,641.32 |
| 2022-08-01 | Kirk Jennifer M | officer: Chief Accounting Officer | 5,909 | A-Award | A | 5,909 | 0.00 | 0.00 |
| 2022-08-01 | Kirk Jennifer M | officer: Chief Accounting Officer | 10,630 | A-Award | A | 2,364 | 0.00 | 0.00 |
| 2022-08-01 | Surface Carol A | officer: EVP, Chief HR Officer | 40,754 | A-Award | A | 40,754 | 93.08 | 3,793,382.32 |
| 2022-08-01 | Surface Carol A | officer: EVP, Chief HR Officer | 12,893 | A-Award | A | 12,893 | 0.00 | 0.00 |
| 2022-08-01 | Surface Carol A | officer: EVP, Chief HR Officer | 26,193 | A-Award | A | 5,157 | 0.00 | 0.00 |
| 2022-08-01 | WHITE ROBERT JOHN | officer: EVP & Pres. Medical Surgical | 67,924 | A-Award | A | 67,924 | 93.08 | 6,322,365.92 |
| 2022-08-01 | WHITE ROBERT JOHN | officer: EVP & Pres. Medical Surgical | 21,487 | A-Award | A | 21,487 | 0.00 | 0.00 |
| 2022-08-01 | WHITE ROBERT JOHN | officer: EVP & Pres. Medical Surgical | 36,351 | A-Award | A | 8,595 | 0.00 | 0.00 |
| 2022-08-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 54,849 | A-Award | A | 54,849 | 93.08 | 5,105,344.92 |
| 2022-08-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 17,351 | A-Award | A | 17,351 | 0.00 | 0.00 |
| 2022-08-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 37,722 | A-Award | A | 6,941 | 0.00 | 0.00 |
| 2022-08-01 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 84,905 | A-Award | A | 84,905 | 93.08 | 7,902,957.40 |
| 2022-08-01 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 26,859 | A-Award | A | 26,859 | 0.00 | 0.00 |
| 2022-08-01 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 30,962 | A-Award | A | 10,744 | 0.00 | 0.00 |
| 2022-08-01 | Martha Geoffrey | director, officer: Chairman and CEO | 224,996 | A-Award | A | 224,996 | 93.08 | 20,942,627.68 |
| 2022-08-01 | Martha Geoffrey | director, officer: Chairman and CEO | 71,176 | A-Award | A | 71,176 | 0.00 | 0.00 |
| 2022-08-01 | Martha Geoffrey | director, officer: Chairman and CEO | 102,497 | A-Award | A | 28,471 | 0.00 | 0.00 |
| 2022-07-29 | Wall Brett A. | officer: EVP & Pres Neuroscience | 18,125 | D-Return | D | 7,493 | 0.00 | 0.00 |
| 2022-07-29 | TEN HOEDT ROB | officer: EVP & President EMEA | 36,177 | D-Return | D | 9,641 | 0.00 | 0.00 |
| 2022-07-29 | Liddicoat John R | officer: EVP & President of Americas | 37,374 | D-Return | D | 6,543 | 0.00 | 0.00 |
| 2022-07-29 | Salmon Sean | officer: EVP & President Cardiovascular | 27,619 | D-Return | D | 5,808 | 0.00 | 0.00 |
| 2022-07-29 | Surface Carol A | officer: EVP, Chief HR Officer | 21,036 | D-Return | D | 7,920 | 0.00 | 0.00 |
| 2022-07-29 | WHITE ROBERT JOHN | officer: EVP & Pres. Medical Surgical | 27,756 | D-Return | D | 12,397 | 0.00 | 0.00 |
| 2022-07-29 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 20,218 | D-Return | D | 15,151 | 0.00 | 0.00 |
| 2022-07-29 | Martha Geoffrey | director, officer: Chairman and CEO | 74,026 | D-Return | D | 23,410 | 0.00 | 0.00 |
| 2022-05-03 | Goldsmith Andrea Jo | director | 4,450 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-03 | ANDERSON RICHARD H | director | 110,182 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-03 | Powell Kendall J | director | 37,417 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-03 | OLEARY DENISE M | director | 70,917 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-03 | NABEL ELIZABETH G | director | 11,818 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-03 | Lofton Kevin E | director | 2,374 | F-InKind | D | 161 | 103.11 | 16,600.71 |
| 2022-05-03 | HOGAN RANDALL J | director | 4,147 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-03 | DONNELLY SCOTT C | director | 14,862 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-03 | ARNOLD CRAIG | director | 34,419 | F-InKind | D | 262 | 103.11 | 27,014.82 |
| 2022-05-02 | Goldsmith Andrea Jo | director | 4,712 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | ANDERSON RICHARD H | director | 110,444 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | Powell Kendall J | director | 37,679 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | OLEARY DENISE M | director | 71,179 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | NABEL ELIZABETH G | director | 12,080 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | Lofton Kevin E | director | 2,535 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | HOGAN RANDALL J | director | 4,409 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | DONNELLY SCOTT C | director | 15,124 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-05-02 | ARNOLD CRAIG | director | 34,681 | A-Award | A | 1,697 | 0.00 | 0.00 |
| 2022-03-18 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 34,946 | S-Sale | D | 682 | 110.00 | 75,020.00 |
| 2022-03-11 | Surface Carol A | officer: SVP, Chief HR Officer | 28,502 | S-Sale | D | 6,000 | 105.30 | 631,800.00 |
| 2022-02-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 21,238 | A-Award | A | 21,238 | 0.00 | 0.00 |
| 2022-02-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 145,852 | A-Award | A | 145,852 | 103.59 | 15,108,808.68 |
| 2022-02-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 15,591 | A-Award | A | 15,591 | 0.00 | 0.00 |
| 2022-02-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 50,476 | A-Award | A | 50,476 | 103.59 | 5,228,808.84 |
| 2022-02-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 30,371 | A-Award | A | 24,134 | 0.00 | 0.00 |
| 2022-02-01 | Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 6,237 | A-Award | A | 6,237 | 0.00 | 0.00 |
| 2022-02-01 | Kirk Jennifer M | officer: Chief Accounting Officer | 7,934 | F-InKind | D | 636 | 103.59 | 65,883.24 |
| 2021-12-23 | WHITE ROBERT JOHN | officer: EVP & Pres. Medical Surgical | 39,430 | S-Sale | D | 7,218 | 102.04 | 736,524.72 |
| 2021-12-16 | ANDERSON RICHARD H | director | 108,374 | P-Purchase | A | 5,010 | 103.26 | 517,332.60 |
| 2021-12-15 | Salmon Sean | officer: EVP & Pres Diabetes/Cardiovasc | 33,083 | F-InKind | D | 89 | 104.94 | 9,339.66 |
| 2021-12-06 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 35,446 | S-Sale | D | 682 | 110.00 | 75,020.00 |
| 2021-12-06 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 49,859 | G-Gift | A | 49,859 | 0.00 | 0.00 |
| 2021-12-06 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 0 | G-Gift | D | 49,859 | 0.00 | 0.00 |
| 2021-11-05 | WHITE ROBERT JOHN | officer: EVP & Pres. Medical Surgical | 46,648 | F-InKind | D | 246 | 122.98 | 30,253.08 |
| 2021-11-05 | Wall Brett A. | officer: EVP & Pres Neuroscience | 25,251 | F-InKind | D | 238 | 122.98 | 29,269.24 |
| 2021-11-05 | Salmon Sean | officer: EVP & Pres Diabetes/Cardiovasc | 33,172 | F-InKind | D | 245 | 122.98 | 30,130.10 |
| 2021-11-05 | Lerman Bradley E | officer: SVP General Counsel & Corp Sec | 48,635 | F-InKind | D | 250 | 122.98 | 30,745.00 |
| 2021-11-05 | Liddicoat John R | officer: EVP & President of Americas | 42,998 | F-InKind | D | 139 | 122.98 | 17,094.22 |
| 2021-11-05 | Kuntz Richard | officer: SVP & Chief Medical & Science | 74,945 | F-InKind | D | 209 | 122.98 | 25,702.82 |
| 2021-11-01 | TEN HOEDT ROB | officer: EVP & President EMEA | 2,080 | A-Award | A | 2,080 | 0.00 | 0.00 |
| 2021-11-01 | TEN HOEDT ROB | officer: EVP & President EMEA | 6,670 | A-Award | A | 6,670 | 120.23 | 801,934.10 |
| 2021-11-01 | TEN HOEDT ROB | officer: EVP & President EMEA | 45,418 | A-Award | A | 832 | 0.00 | 0.00 |
| 2021-10-08 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 49,859 | G-Gift | A | 12,000 | 0.00 | 0.00 |
| 2021-10-08 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 35,974 | G-Gift | D | 12,000 | 0.00 | 0.00 |
| 2021-10-06 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 37,859 | G-Gift | A | 37,859 | 0.00 | 0.00 |
| 2021-10-06 | PARKHILL KAREN L | officer: EVP & Chief Financial Officer | 47,974 | G-Gift | D | 37,859 | 0.00 | 0.00 |
| 2021-09-30 | Lerman Bradley E | officer: SVP General Counsel & Corp Sec | 97,910 | M-Exempt | A | 49,147 | 78.00 | 3,833,466.00 |
| 2021-09-30 | Lerman Bradley E | officer: SVP General Counsel & Corp Sec | 0 | M-Exempt | D | 49,147 | 78.00 | 3,833,466.00 |
| 2021-09-30 | Lerman Bradley E | officer: SVP General Counsel & Corp Sec | 48,763 | S-Sale | D | 49,147 | 126.58 | 6,221,027.26 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.